These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15798414)

  • 61. Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls.
    Mithani S; Zaidi Z
    J Pak Med Assoc; 2005 Sep; 55(9):371-3. PubMed ID: 16302469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers.
    Zhang J; Kumar S; Jayachandran M; Herrera Hernandez LP; Wang S; Wilson EM; Lieske JC
    BMC Nephrol; 2021 Jun; 22(1):204. PubMed ID: 34074247
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The impact of dietary calcium and oxalate ratios on stone risk.
    Lange JN; Wood KD; Mufarrij PW; Callahan MF; Easter L; Knight J; Holmes RP; Assimos DG
    Urology; 2012 Jun; 79(6):1226-9. PubMed ID: 22480460
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical significance of phosphate in calcium oxalate renal stones.
    Ohman S; Larsson L; Tiselius HG
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urinary stone risk factors in the descendants of patients with kidney stone disease.
    Dissayabutra T; Kalpongkul N; Rattanaphan J; Boonla C; Srisa-Art M; Ungjaroenwathana W; Tosukhowong P
    Pediatr Nephrol; 2018 Jul; 33(7):1173-1181. PubMed ID: 29594505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preservation of urine samples for metabolic evaluation of stone-forming patients.
    Ferraz RR; Baxmann AC; Ferreira LG; Nishiura JL; Siliano PR; Gomes SA; Moreira SR; Heilberg IP
    Urol Res; 2006 Oct; 34(5):329-37. PubMed ID: 16896690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimating 24-hour urinary excretion using spot urine measurements in kidney stone formers.
    Ferraro PM; Lopez F; Petrarulo M; Barbarini S; Curhan GC; Marangella M; Taylor EN
    Nephrol Dial Transplant; 2022 Oct; 37(11):2171-2179. PubMed ID: 35146503
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D; Thind SK; Gupta GS; Nath R
    Urol Res; 1991; 19(3):203-6. PubMed ID: 1887530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Risk factors for the formation of urinary calcium-containing stones in diabetics].
    Liu JG; Hu M; He XQ
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):649-53, 699-700. PubMed ID: 2632175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.